Dapagliflozin Shows Promising Efficacy and Safety in Pediatric HFrEF: Study Jacinthlyn Sylvia15 May 2026 9:00 AM ISTA new study published in the Frontiers in Cardiovascular Medicine showed that Dapagliflozin improved key cardiac parameters in children with heart...
Dapagliflozin & Sitagliptin Combination Emerges as Effective Strategy in T2DM Care Dr. Bhumika Maikhuri4 May 2026 11:30 AM ISTIn this video, Dr Sunil Gupta, Diabetologist, CEO & MD, Sunil's Diabetes Care n' Research Centre Pvt. Ltd, Nagpur, discusses about the...
Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths MD Bureau23 April 2026 11:45 AM ISTMumbai: Pharma major Lupin Ltd on Wednesday announced the launch of its generic version of anti-diabetic medicine dapagliflozin and metformin...
Add on Dapagliflozin to Insulin Pump Superior to add on Metformin for Glycemic Control in Diabetes: Study Dr Riya Dave13 April 2026 9:30 AM ISTResearchers have found in a new study that dapagliflozin combined with intensive insulin pump therapy provides better glycemic control than metformin...
Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin-Metformin Tablets Parthika Patel10 April 2026 9:14 PM ISTNew Delhi: Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin...
Lupin, Zydus Secure USFDA Nod for Dapagliflozin Tablets Parthika Patel9 April 2026 5:50 PM ISTNew Delhi: Lupin Limited and Zydus Lifesciences Limited have received approval from the United States Food and Drug Administration (USFDA) for...
Dapagliflozin and Sitagliptin FDC in Indian T2D: 5 Points Clinicians May Like to Know - Dr K Baraneedharan Dr. K. Baraneedharan9 April 2026 12:00 PM ISTThe burden of T2DM is increasing worldwide, with enormous implications for morbidity and mortality. Early and effective intervention is essential to...
Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day Exclusivity Parthika Patel8 April 2026 9:22 PM ISTNew Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and...
USFDA Approves Alembic's Dapagliflozin Tablets, Grants 180-Day Exclusivity Parthika Patel8 April 2026 8:47 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (USFDA) for its...
Eris Lifesciences Asked to Revise Phase IV Protocol for Dapagliflozin, Gliclazide, Metformin FDC Susmita Roy2 April 2026 6:02 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined that Eris...
Integrating Dapagliflozin and Sitagliptin FDC for Optimizing Outcomes in Type-2 Diabetes with Cardiometabolic-Based Chronic Disease (CMBCD) patients - Dr Kaushik Biswas Dr. Kaushik Biswas28 March 2026 10:27 AM ISTIntroduction India's T2D population carries a substantial burden-nearly two-thirds of individuals with T2D are overweight or obese, indicating a...
Dapagliflozin May Reduce Liver Fat in Type 2 Diabetes Independent of Weight Loss: Study Dr Riya Dave24 Feb 2026 9:30 AM ISTResearchers have found in a secondary analysis of a clinical trial published in Obesity that taking dapagliflozin 10 mg daily for 12 months was...
